🇺🇸 FDA
Pipeline program

Plasma exchange

199/11693

Phase 3 other active

Quick answer

Plasma exchange for Acute Disseminated Encephalomyelitis is a Phase 3 program (other) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Acute Disseminated Encephalomyelitis
Phase
Phase 3
Modality
other
Status
active

Clinical trials